These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2. Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938 [No Abstract] [Full Text] [Related]
25. The role of microbiota in esophageal squamous cell carcinoma: A review of the literature. Chiang HC; Hughes M; Chang WL Thorac Cancer; 2023 Oct; 14(28):2821-2829. PubMed ID: 37675608 [TBL] [Abstract][Full Text] [Related]
26. Interleukin-33-nuclear factor-κB-CCL2 signaling pathway promotes progression of esophageal squamous cell carcinoma by directing regulatory T cells. Yue Y; Lian J; Wang T; Luo C; Yuan Y; Qin G; Zhang B; Zhang Y Cancer Sci; 2020 Mar; 111(3):795-806. PubMed ID: 31883400 [TBL] [Abstract][Full Text] [Related]
27. HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway. Wang H; Yang X; Guo Y; Shui L; Li S; Bai Y; Liu Y; Zeng M; Xia J J Exp Clin Cancer Res; 2019 Jul; 38(1):324. PubMed ID: 31331361 [TBL] [Abstract][Full Text] [Related]
28. Oral Administration of Song JM; Woo BH; Lee JH; Yoon S; Cho Y; Kim YD; Park HR Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31117164 [TBL] [Abstract][Full Text] [Related]
29. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma. Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896 [TBL] [Abstract][Full Text] [Related]
30. Role of ALDH1 in the prognosis of esophageal cancer and its relationship with tumor microenvironment. Chen MF; Chen PT; Lu MS; Chen WC Mol Carcinog; 2018 Jan; 57(1):78-88. PubMed ID: 28888039 [TBL] [Abstract][Full Text] [Related]
31. Liu S; Zhou X; Peng X; Li M; Ren B; Cheng G; Cheng L J Immunol; 2020 Jul; 205(1):282-289. PubMed ID: 32471882 [TBL] [Abstract][Full Text] [Related]
32. Role of Porphyromonas gingivalis in oral squamous cell carcinoma development: A systematic review. Lafuente Ibáñez de Mendoza I; Maritxalar Mendia X; García de la Fuente AM; Quindós Andrés G; Aguirre Urizar JM J Periodontal Res; 2020 Jan; 55(1):13-22. PubMed ID: 31529626 [TBL] [Abstract][Full Text] [Related]
34. Overexpression of JAB1 promotes malignant behavior and predicts poor prognosis in esophageal squamous cell carcinoma. Shen Q; Shang B; Jiang B; Wang Y; Wang Z; Chen G Thorac Cancer; 2020 Apr; 11(4):973-982. PubMed ID: 32064781 [TBL] [Abstract][Full Text] [Related]
35. Porphyromonas gingivalis promotes the progression of oral squamous cell carcinoma by activating the neutrophil chemotaxis in the tumour microenvironment. Guo ZC; Jing SL; Jumatai S; Gong ZC Cancer Immunol Immunother; 2023 Jun; 72(6):1523-1539. PubMed ID: 36513851 [TBL] [Abstract][Full Text] [Related]
36. IFI6 depletion inhibits esophageal squamous cell carcinoma progression through reactive oxygen species accumulation via mitochondrial dysfunction and endoplasmic reticulum stress. Liu Z; Gu S; Lu T; Wu K; Li L; Dong C; Zhou Y J Exp Clin Cancer Res; 2020 Jul; 39(1):144. PubMed ID: 32727517 [TBL] [Abstract][Full Text] [Related]
37. Role of Nutritional Status in the Treatment Outcome for Esophageal Squamous Cell Carcinoma. Chen MF; Hsieh CC; Chen PT; Lu MS Nutrients; 2021 Aug; 13(9):. PubMed ID: 34578883 [TBL] [Abstract][Full Text] [Related]
38. Serum Levels of Interleukin-6 and Titers of Antibodies Against Park DG; Woo BH; Lee BJ; Yoon S; Cho Y; Kim YD; Park HR; Song JM Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31167516 [TBL] [Abstract][Full Text] [Related]
39. The relationship between Kong J; Liu Y; Qian M; Xing L; Gao S Epidemiol Infect; 2023 Apr; 151():e69. PubMed ID: 37009715 [TBL] [Abstract][Full Text] [Related]
40. Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma. Liu Q; Cui X; Yu X; Bian BS; Qian F; Hu XG; Ji CD; Yang L; Ren Y; Cui W; Zhang X; Zhang P; Wang JM; Cui YH; Bian XW Mol Cancer; 2017 Apr; 16(1):81. PubMed ID: 28431580 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]